↓ Skip to main content
What is this page? Embed badge

Myths and Shibboleths in Nephrology

Overview of attention for book
Cover of 'Myths and Shibboleths in Nephrology'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Myth: Urinary tract infection can lead to end-stage renal disease (ESRD)
  3. Altmetric Badge
    Chapter 2 Myth: Kidney donation does not jeopardize function in the remaining kidney
  4. Altmetric Badge
    Chapter 3 Myth: Hypertension imposes a risk of chronic kidney failure
  5. Altmetric Badge
    Chapter 4 Myth: Angiotensin converting enzyme inhibitors (ACEi) are superior to other antihypertensive drugs because of their renoprotective properties
  6. Altmetric Badge
    Chapter 5 Myth: Dietary protein restriction slows progression of renal insufficiency
  7. Altmetric Badge
    Chapter 6 Myth: Plasmapheresis is beneficial in some renal disorders
  8. Altmetric Badge
    Chapter 7 Myth: Urinary tract infection is more prevalent in diabetes
  9. Altmetric Badge
    Chapter 8 Myth: Type 1 diabetes is more likely than type 2 diabetes to lead to nephropathy and ESRD
  10. Altmetric Badge
    Chapter 9 Myth: Pharmacological strategies may prevent acute tubular necrosis (ATN)
  11. Altmetric Badge
    Chapter 10 Myth: Intravenous iron may be hazardous in infected hemodialysis patients
  12. Altmetric Badge
    Chapter 11 Myth: Peritoneal dialysis is equivalent to hemodialysis
  13. Altmetric Badge
    Chapter 12 Myth: Rationing of ESRD treatment is an unavoidable reality
  14. Altmetric Badge
    Chapter 13 Myth: Tacrolimus is superior to cyclosporine in renal transplantation
  15. Altmetric Badge
    Chapter 14 Myth: Dialyzer re-use is safe and cost effective
  16. Altmetric Badge
    Chapter 15 Myth: Living related pancreas after kidney transplantation is preferable to cadaveric simultaneous pancreas-kidney transplantation
  17. Altmetric Badge
    Chapter 16 Myth: Administration of active vitamin D metabolites is beneficial in patients with advanced chronic renal failure (pre end-stage renal disease)
  18. Altmetric Badge
    Chapter 17 Myth: Surgical intervention and prompt nephrectomy are preferred in emphysematous pyelonephritis
  19. Altmetric Badge
    Chapter 18 Myth: Mortality in chronic hemodialysis is greater in the U.S. than in Europe and Japan
  20. Altmetric Badge
    Chapter 19 Myth: A single hemodialysis treatment prevents uremic bleeding and restores platelet function
  21. Altmetric Badge
    Chapter 20 Myth: Kidney biopsy is indicated in every case of lupus nephritis
  22. Altmetric Badge
    Chapter 21 Myth: Indicators of glycemic control in diabetic ESRD patients should be equivalent to those utilized in earlier stages of diabetic nephropathy
  23. Altmetric Badge
    Chapter 22 Myth: Fish oil is effective therapy for IgA nephropathy
  24. Altmetric Badge
    Chapter 23 Myth: Physician assistants should replace nephrologists in dialysis units
  25. Altmetric Badge
    Chapter 24 Myth: Patients with severe cerebrovascular accidents (CVA) require long-term bladder catheters
  26. Altmetric Badge
    Chapter 25 Myth: Pre-transplant blood transfusions enhance renal allograft survival
  27. Altmetric Badge
    Chapter 26 Myth: Hemoperfusion is superior to hemodialysis in the treatment of certain poisonings and/or drug overdoses
  28. Altmetric Badge
    Chapter 27 Epilogue
Attention for Chapter 6: Myth: Plasmapheresis is beneficial in some renal disorders
Altmetric Badge
Summary
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Myth: Plasmapheresis is beneficial in some renal disorders
Chapter number 6
Book title
Myths and Shibboleths in Nephrology
Published by
Springer, Dordrecht, January 2002
DOI 10.1007/978-94-010-0407-7_6
Book ISBNs
978-1-4020-0616-6, 978-9-40-100407-7
Authors

Leila J. Macey

View on publisher site

This page is provided by Altmetric.